|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2100048356 |
|
最近更新日期: Date of Last Refreshed on: |
2021-07-06 01:03:42 |
|
注册时间: Date of Registration: |
2021-07-06 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
脊髓损伤后肌肉萎缩机理研究 |
|
Public title: |
Mechanism of muscular atrophy after spinal cord injury |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
脊髓损伤后肌肉萎缩机理研究 |
|
Scientific title: |
Mechanism of muscular atrophy after spinal cord injury |
|
研究课题代号(代码): Study subject ID: |
瑞金医院院内课题2019ZY12 |
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
纵亚 |
研究负责人: |
纵亚 |
|
Applicant: |
Ya Zong |
Study leader: |
Ya Zong |
|
申请注册联系人电话: Applicant telephone: |
18017026518 |
研究负责人电话: Study leader's telephone: |
18017026518 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
zongya@163.com |
研究负责人电子邮件: Study leader's E-mail: |
zongya@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
上海市瑞金二路197号 |
研究负责人通讯地址: |
上海市瑞金二路197号 |
|
Applicant address: |
No. 197 Ruijin Er Road |
Study leader's address: |
No. 197 Ruijin Er Road |
|
申请注册联系人邮政编码: Applicant postcode: |
200025 |
研究负责人邮政编码: Study leader's postcode: |
200025 |
|
申请人所在单位: |
上海交通大学医学院附属瑞金医院 |
||
|
Applicant's institution: |
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine |
||
|
研究负责人所在单位: |
上海交通大学医学院附属瑞金医院 |
||
|
Affiliation of the Leader: |
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
(2021)临伦审第(162)号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
上海交通大学医学院附属瑞金医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2021-06-09 00:00:00 |
||
|
伦理委员会联系人: |
王译锋 |
||
|
Contact Name of the ethic committee: |
Yifeng Wang |
||
|
伦理委员会联系地址: |
上海市瑞金二路197号 |
||
|
Contact Address of the ethic committee: |
No. 197 Ruijin Er Road |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
0086-021-64370045 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
keyanxiangmu@163.com |
|
研究实施负责(组长)单位: |
上海交通大学医学院附属瑞金医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
上海市瑞金二路197号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 197 Ruijin Er Road |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
瑞金医院院内课题 |
||||||||||||||||||||||
|
Source(s) of funding: |
fund of Ruijin Hospital |
||||||||||||||||||||||
|
Target disease: |
Spinal Cord Injury |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
治疗新技术临床试验 | ||||||||||||||||||||||
|
Study phase: |
New Treatment Measure Clinical Study |
||||||||||||||||||||||
|
研究设计: |
非随机对照试验 |
||||||||||||||||||||||
|
Study design: |
Non randomized control |
||||||||||||||||||||||
|
研究目的: |
主要研究目的:采用 CMAP scan MUNE技术,对脊髓损伤后的 MU的特性、肌肉结构变化等关键问题展开研究,探索SCI后产生的神经肌肉变化。次要研究目的:建立正常受试者FDI的MU正常参考值并探索CMAP scan MUNE 对SCI患者MU减少的判定标准。 |
||||||||||||||||||||||
|
Objectives of Study: |
The main objective of this study was to explore the neuromuscular changes after SCI.The method was to study the characteristics and the changes of muscle structure of motor unit after spinal cord injury(SCI) via motor unit(MU) number estimation(MUNE) from compound muscle action potential(CMAP) scan. The secondary objective of this study was to establish the normal reference value of Mu in the first dorsal interosseous (FDI) muscle of normal subjects, and to explore the criteria of CMAP scan MUNE for judging the Mu decrease in SCI patients. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
观察组脊髓损伤患者给予每周3次的经颅磁刺激治疗,连续4周。磁刺激放在观察侧对侧大脑皮层运动区投影处,以诱发出FDI收缩确定治疗阈值和磁刺激位置。 |
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
The patients in the observation group were given transcranial magnetic stimulation three times a week for four weeks. Magnetic stimulation was placed on the contralateral projection of the motor area of the cerebral cortex to induce FDI contraction and determine the treatment threshold and magnetic stimulation location. |
||||||||||||||||||||||
|
纳入标准: |
(1)受试者签署书面知情同意书,表明其理解了试验目的和过程,并愿意参加试验; |
||||||||||||||||||||||
|
Inclusion criteria |
(1) The subject signs a written informed consent form, indicating that they understand the purpose and process of the trial and are willing to participate in the trial; |
||||||||||||||||||||||
|
排除标准: |
(1)不签署知情同意书 |
||||||||||||||||||||||
|
Exclusion criteria: |
(1) No informed consent; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2021-07-12 00:00:00至 To 2024-06-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2021-07-12 00:00:00 至 To 2023-09-30 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
非随机对照 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Non randomized controlled trial |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
否 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
no |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Record Form |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |